In their article, Singh et al. describe their protocol on preemptive therapy in CMV pp65-
antigen positive liver transplant recipients, 1 which was implemented 13 years ago and led …

To determine whether cytomegalovirus (CMV) disease is an independent risk factor for graft
loss and death after orthotopic liver transplantation, we performed a 3-year follow-up study …

The most common organ‐specific manifestation of cytomegalovirus (CMV) infection after
liver transplantation is hepatitis. Here we retrospectively describe the detailed virological …

Background Cytomegalovirus (CMV) infection and disease are preventable complications
following pediatric liver transplantation (PLT), despite the use of prophylaxis to minimize the …

Cytomegalovirus (CMV) infection causes significant morbidity and mortality among
transplant recipients. Although it is still not clear if a preemptive strategy is superior to a …

Background Most pediatric liver transplantation (LT) centers administer long courses of
prophylaxis against cytomegalovirus (CMV) without evidence of benefit and with significant …

The purpose of this study was to identify factors associated with the development of
cytomegalovirus (CMV) disease and to assess the morbidity of this illness in pediatric renal …

Background PTLD is a clinical condition with high mortality. Monitoring EBV replication can
be a useful tool to avoid the development of PTLD. Materials and Methods This was a …

Cytomegalovirus (CMV) is the most common opportunistic infection following solid organ
transplantation. Prevention and management of CMV infection has assumed a higher …

Martin JM, Danziger‐Isakov LA. Cytomegalovirus risk, prevention, and management in
pediatric solid organ transplantation. Pediatr Transplantation 2011: 15: 229–236.© 2010 …